id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1975-N-0336-0121,FDA,FDA-1975-N-0336,"Drugs for Human Use; Drug Efficacy Study Implementation; Oral Prescription Drugs Containing an Anticholinergic or Antispasmodic in Combination With a Sedative, and
Single-Entity Antispasmodic Drug Products, in Oral Dosage Form; Withdrawal of Hearing Requests; Final Resolution of Drug Efficacy Study Implementation",Notice,Announcement,2022-04-25T04:00:00Z,2022,4,2022-04-25T04:00:00Z,,2022-04-25T12:23:39Z,2022-08740,0,0,0900006485031b82